Eczema Clinical Trial
Enrolling Now

Clinics: Greater Manchester, Merseyside, West Yorkshire

Therapy Area: Atopic Dermatitis

Gender and Age: Males & Females aged 18 – 65

Reimbursement: Between £1135 and £2250

About The Research...

Eczema, also known as atopic dermatitis, is one of the most common types of skin diseases. The common feature of this inflammatory skin disease is itching. Eczema often relapses, meaning symptoms will improve for a while but then return. Currently there is no cure for the disease.


Many people with eczema improve their condition and relieve their symptoms using moisturising treatments and drugs such as steroid creams, lifestyle changes and phototherapy (treatment with light). However, for about one-fifth of people with moderate to severe forms of eczema these treatments are not as effective especially in the long term.

At MAC Clinical Research we understand there is a need for new and improved treatments, and we are conducting a clinical trial to test a new topical ointment.

Up to 130 eligible participants will receive the study drug or matching placebo (a ‘dummy medication’ containing no active ingredient or drug)

This trial will run at our Greater Manchester, Merseyside and West Yorkshire clinics. Part A will run at our Manchester clinic and will consist of 40 patients over 4 cohorts. Sentinel patients in Cohort 1 and 2 will receive £2,250. Remaining patients in Cohort 1 and 2 will receive £1,650. Patients in cohorts 3 and 4 will receive £2,010.

Part B will run at our Leeds, Liverpool and Manchester clinics and will consist of up to 90 patients who will receive £1,135.

Reimbursement: Between £1135 and £2250

Criteria:

* Key Inclusion Criteria:

  • Male or female aged 18 – 65.
  • Diagnosis of eczema for at least the 6 months.
  • BMI 18 – 30, minimum weight 50kg.

 

* Key Exclusion Criteria:

  • Unwilling to stop using current eczema treatments.

 

Other eligibility criteria will apply. Please contact MAC for more information.

Any other information

Eligible patients will receive a comprehensive health screen and study participation will be in collaboration with the participants’ treating physician.

MAC Clinical Research is conducting a trial to evaluate a potential new treatment for eczema.

If you would like more information, please fill in the form below and we will be in touch…

Alternatively, please call our recruitment team on freephone 0800 633 5507.

  • (You can enter any supporting information here)
Data Privacy Statement

Know someone who may be interested in taking part? Share this page here:

Share on facebook
Facebook
Share on twitter
Twitter
Share on whatsapp
WhatsApp
Share on email
Email